| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |